Naomi P. Thomas

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trial.

Mavodelpar in patients with primary mitochondrial myopathy: a phase 1 trial.

Journal: Scientific reports
Published: December 11, 2025

Adjunctive transcranial DC stimulation in the management of refractory drug-resistant focal epilepsy in POLG mitochondrial disease: A case series.

Adjunctive transcranial DC stimulation in the management of refractory drug-resistant focal epilepsy in POLG mitochondrial disease: A case series.

Journal: Seizure
Published: April 14, 2025

Optimizing rare disorder trials: a phase 1a/1b randomized study of KL1333 in adults with mitochondrial disease.

Optimizing rare disorder trials: a phase 1a/1b randomized study of KL1333 in adults with mitochondrial disease.

Journal: Brain : a journal of neurology
Published: May 30, 2024

Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy.

Correction: Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy.

Journal: Trials
Published: October 05, 2022

Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy.

Acipimox in Mitochondrial Myopathy (AIMM): study protocol for a randomised, double-blinded, placebo-controlled, adaptive design trial of the efficacy of acipimox in adult patients with mitochondrial myopathy.

Journal: Trials
Published: April 25, 2022

Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study.

Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study.

Journal: Brain communications
Published: May 24, 2021

Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study.

Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study.

Journal: The Lancet. Child & adolescent health
Published: May 08, 2021

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.

Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study.

Journal: The lancet. Psychiatry
Published: May 26, 2020

Defining causality in COVID-19 and neurological disorders.

Defining causality in COVID-19 and neurological disorders.

Journal: Journal of neurology, neurosurgery, and psychiatry
Published: April 28, 2020

Do virtual renal clinics improve access to kidney care? A preliminary impact evaluation of a virtual clinic in East London.

Do virtual renal clinics improve access to kidney care? A preliminary impact evaluation of a virtual clinic in East London.

Journal: BMC nephrology
Published: July 10, 2019

Genetic chameleons: remember the relapsing disorders.

Genetic chameleons: remember the relapsing disorders.

Journal: Practical neurology
Published: February 18, 2019

The challenge of nutritional management in people with kidney disease.

The challenge of nutritional management in people with kidney disease.

Journal: Journal of human nutrition and dietetics : the official journal of the British Dietetic Association
Published: October 31, 2017
Showing 1-12 of 13

Last Updated: 09/26/2026